| scholarly article | Q13442814 |
| P2093 | author name string | Amit M | |
| Skorecki KL | |||
| Tzukerman M | |||
| Itskovitz-Eldor J | |||
| Maor G | |||
| Assady S | |||
| P2860 | cites work | Embryonic stem cell lines derived from human blastocysts | Q27861010 |
| Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells | Q28590205 | ||
| Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro | Q29617383 | ||
| Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture | Q40843384 | ||
| Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue | Q45872828 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| human embryonic stem cell | Q59626782 | ||
| P304 | page(s) | 1691-1697 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Insulin production by human embryonic stem cells | |
| P478 | volume | 50 |
| Q41459994 | A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells |
| Q40577493 | A glimmer of hope for diabetics? |
| Q40368491 | A human beta-cell line for transplantation therapy to control type 1 diabetes. |
| Q34922338 | A molecular view on pluripotent stem cells |
| Q37409348 | A role for islet neogenesis in curing diabetes. |
| Q40242890 | A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones |
| Q37037714 | Adult Stem Cell Plasticity: Dream or Reality? |
| Q45864087 | Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach. |
| Q35879304 | Advances in tissue engineering |
| Q39370965 | Alternatives to islet transplantation: future cell sources of beta-like cells |
| Q35087641 | Alternatives to unmodified human islets for transplantation |
| Q38557710 | An arduous journey from human pluripotent stem cells to functional pancreatic β cells. |
| Q37089436 | An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells |
| Q28198165 | An overview of stem cell research and regulatory issues |
| Q35823969 | Animal models to study adult stem cell-derived, in vitro-generated islet implantation |
| Q91743529 | Application of Tonsil-Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise Review |
| Q37609481 | Are stem cells a cure for diabetes? |
| Q37158532 | Bioartificial pancreas for the treatment of diabetes |
| Q37043519 | Blood into beta-cells: can adult stem cells be used as a therapy for Type 1 diabetes? |
| Q39431694 | Brief review: cell replacement therapies to treat type 1 diabetes mellitus |
| Q43096569 | CD45+/CD133+ positive cells expanded from umbilical cord blood expressing PDX-1 and markers of pluripotency |
| Q27002327 | Can pluripotent stem cells be used in cell-based therapy? |
| Q36362625 | Cell replacement in type 1 diabetes mellitus |
| Q36672119 | Cell replacement therapy and the evasion of destructive immunity |
| Q34735277 | Cell replacement therapy for type 1 diabetes |
| Q40705949 | Cell therapies and regenerative medicine |
| Q35684842 | Cell therapies for type 1 diabetes mellitus |
| Q38124849 | Cell therapy for cystic fibrosis |
| Q36735591 | Cell therapy for diabetes mellitus |
| Q35781209 | Cell therapy using human embryonic stem cells |
| Q44004821 | Characterization and Isolation of Promoter-Defined Nestin-Positive Cells from the Human Fetal Pancreas |
| Q81820540 | Characterization and culture of human embryonic stem cells |
| Q46513700 | Characterization and evaluation of human embryonic stem cells |
| Q34076010 | Characterization of the expression of MHC proteins in human embryonic stem cells |
| Q41893785 | Characterization of vector-based delivery of neurogenin-3 in murine diabetes |
| Q35179365 | Clinical islet transplantation |
| Q36672090 | Cloned human embryonic stem cells for tissue repair and transplantation |
| Q85929748 | Closing in on pancreatic beta cells |
| Q26999928 | Concise review: in search of unlimited sources of functional human pancreatic beta cells |
| Q77658497 | Connecting islet development and developing useful islets |
| Q36804546 | Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny. |
| Q37621220 | Converting human pluripotent stem cells into beta-cells: recent advances and future challenges |
| Q35019154 | Current features of preimplantation genetic diagnosis. |
| Q28240432 | Current status of regeneration of pancreatic β-cells |
| Q34595854 | Defined culture conditions of human embryonic stem cells |
| Q39859389 | Derivation and characterization of human embryonic stem cell lines from poor quality embryos |
| Q34038983 | Derivation and long-term culture of human parthenogenetic embryonic stem cells using human foreskin feeders |
| Q34659107 | Derivation and spontaneous differentiation of human embryonic stem cells |
| Q36385105 | Derivation of clinical-grade human embryonic stem cells. |
| Q43249703 | Derivation of cranial neural crest-like cells from human embryonic stem cells |
| Q39022315 | Derivation of human embryonic stem cell lines without any exogenous growth factors |
| Q57810908 | Designed Functional Dispersion for Insulin Protection from Pepsin Degradation and Skeletal Muscle Cell Proliferation: In Silico and In Vitro Study |
| Q40158668 | Detecting de novo insulin synthesis in embryonic stem cell-derived populations. |
| Q30661642 | Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors |
| Q40239436 | Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures |
| Q37428593 | Development of insulin-producing cells from primitive biologic precursors |
| Q34485165 | Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy |
| Q26748645 | Diabetes treatment: A rapid review of the current and future scope of stem cell research |
| Q35184029 | Diabetic heart dysfunction: is cell transplantation a potential therapy? |
| Q36795992 | Dicer1 is required to repress neuronal fate during endocrine cell maturation |
| Q82477543 | Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells |
| Q90484122 | Differentiation Potential of Nestin (+) and Nestin (-) Cells Derived from Human Bone Marrow Mesenchymal Stem Cells into Functional Insulin Producing Cells |
| Q38168213 | Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells. |
| Q40397881 | Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer |
| Q38971980 | Differentiation of human induced pluripotent stem cells into insulin-like cell clusters with miR-186 and miR-375 by using chemical transfection. |
| Q35752093 | Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells |
| Q39046988 | Differentiation of human skin-derived precursor cells into functional islet-like insulin-producing cell clusters. |
| Q21092394 | Differentiation of insulin-producing cells from human neural progenitor cells |
| Q43084514 | Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. |
| Q52095740 | Differentiation of mouse embryonic stem cells into pancreatic and hepatic cells. |
| Q46051762 | Differentiation of pluripotent stem cells into pancreatic lineages |
| Q36076469 | Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells |
| Q34565279 | Directed differentiation of embryonic stem cells: genetic and epigenetic methods |
| Q50902967 | Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. |
| Q24802550 | Directed differentiation of rhesus monkey ES cells into pancreatic cell phenotypes |
| Q36911189 | Directing human embryonic stem cells to generate vascular progenitor cells |
| Q38749701 | Effective endothelial cell and human pluripotent stem cell interactions generate functional insulin-producing beta cells |
| Q35116178 | Efficient and simple production of insulin-producing cells from embryonal carcinoma stem cells using mouse neonate pancreas extract, as a natural inducer. |
| Q46163301 | Efficient differentiation of insulin-producing cells from skin-derived stem cells. |
| Q46541016 | Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors |
| Q36012093 | Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease |
| Q33844988 | Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows |
| Q54298264 | Embryonic stem cell-based diabetes therapy--a long road to travel. |
| Q34736814 | Embryonic stem cells |
| Q51383633 | Embryonic stem cells and tissue engineering: delivering stem cells to the clinic. |
| Q38047270 | Emerging in vitro models for safety screening of high-volume production nanomaterials under environmentally relevant exposure conditions. |
| Q96686040 | Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy |
| Q37971089 | Encapsulated cell grafts to treat cellular deficiencies and dysfunction |
| Q51167248 | End-stage organ failure: will regenerative medicine keep its promise? |
| Q35176449 | Endocrine pathology in translational medicine: an overview of current and future prospects |
| Q37666725 | Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture |
| Q35109481 | Endothelial cells in co-culture enhance embryonic stem cell differentiation to pancreatic progenitors and insulin-producing cells through BMP signaling. |
| Q26849385 | Endothelium-derived essential signals involved in pancreas organogenesis |
| Q35532294 | Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes |
| Q35844417 | Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells. |
| Q35725808 | Engineering islets: lessons from stem cells and embryonic development |
| Q51094982 | Engineering three-dimensional tissue structures using stem cells. |
| Q39728634 | Establishment and maintenance of three Chinese human embryonic stem cell lines |
| Q33746955 | Establishment of a pancreatic stem cell line from fibroblast-derived induced pluripotent stem cells. |
| Q24321427 | Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells |
| Q33746106 | Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment |
| Q36582408 | Exendin-4 enhances expression of Neurod1 and Glut2 in insulin-producing cells derived from mouse embryonic stem cells |
| Q51426983 | Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. |
| Q30419246 | Exposure to acoustic stimuli promotes the development and differentiation of neural stem cells from the cochlear nuclei through the clusterin pathway |
| Q34328388 | Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells |
| Q24336499 | Expression profiling of nuclear receptors in human and mouse embryonic stem cells |
| Q57821180 | Factors Controlling Human Embryonic Stem Cell Differentiation |
| Q36309740 | Factors influencing the longevity and replacement frequency of Provox voice prostheses |
| Q34537156 | Fifty ways to make a neuron: shifts in stem cell hierarchy and their implications for neuropathology and CNS repair |
| Q34655798 | From teratocarcinomas to embryonic stem cells |
| Q40625453 | Functional endothelial cells derived from rhesus monkey embryonic stem cells |
| Q34647309 | GLP-1 could improve the similarity of IPCs and pancreatic beta cells in cellular ultrastructure and function |
| Q36193186 | Gastrointestinal stem cells. I. Pancreatic stem cells |
| Q53603737 | Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes. |
| Q37566325 | Generation of pancreatic islet cells from human embryonic stem cells. |
| Q60926710 | Generation of pancreatic β cells for treatment of diabetes: advances and challenges |
| Q36293910 | Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications |
| Q42530118 | Glucose responsive insulin production from human embryonic germ (EG) cell derivatives |
| Q35018515 | Glucose-responsive insulin-producing cells from stem cells |
| Q81398936 | Growing organs for transplantation from embryonic precursor tissues |
| Q40603727 | Growth and differentiation of cynomolgus monkey ES cells. |
| Q28535456 | HEXIM1 induces differentiation of human pluripotent stem cells |
| Q40657047 | HNF-6-independent differentiation of mouse embryonic stem cells into insulin-producing cells |
| Q43052736 | Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection |
| Q36606369 | Human embryonic stem cell culture: current limitations and novel strategies. |
| Q47576212 | Human embryonic stem cell derivation: from the IVF perspective to therapeutic applications |
| Q36804578 | Human embryonic stem cell-derived cardiomyocytes: inducing strategies. |
| Q37077702 | Human embryonic stem cells and liver diseases: from basic research to future clinical application |
| Q36545627 | Human embryonic stem cells as a powerful tool for studying human embryogenesis |
| Q35184036 | Human embryonic stem cells for myocardial regeneration |
| Q90304378 | Human embryonic stem cells: Distinct molecular personalities and applications in regenerative medicine |
| Q24615057 | Human embryonic stem cells: derivation, culture, and differentiation: a review |
| Q36309574 | Human embryonic stem cells: possibilities for human cell transplantation. |
| Q57064373 | Human pluripotent stem cells for the modelling of pancreatic beta-cell pathology |
| Q34353192 | Human pluripotent stem cells: a progress report. |
| Q37853194 | Immune and cell therapy in type 1 diabetes: too little too late? |
| Q39666401 | Impact of co-culture on pancreatic differentiation of embryonic stem cells |
| Q46133022 | In Vivo Rescue of the Hematopoietic Niche By Pluripotent Stem Cell Complementation of Defective Osteoblast Compartments. |
| Q36308112 | In vitro cultivation of human fetal pancreatic ductal stem cells and their differentiation into insulin-producing cells |
| Q51027491 | In vitro derivation of functional insulin-producing cells from human embryonic stem cells. |
| Q36108470 | In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. |
| Q35781236 | In vitro-generation of surrogate islets from adult stem cells |
| Q36173435 | In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow |
| Q39911145 | In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells |
| Q92466369 | In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2 |
| Q34692148 | Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny |
| Q91430090 | Induced pluripotent stem cells in disease modelling and drug discovery |
| Q29144285 | Induction of insulin production in rat pancreatic acinar carcinoma cells by conophylline |
| Q46572730 | Insulin secretion by rat lacrimal glands: effects of systemic and local variables |
| Q34951717 | Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies |
| Q34186756 | Insulin-producing cells from human adipose tissue-derived mesenchymal stem cells detected by atomic force microscope |
| Q43030868 | Insulin-producing cells from tissue stem/progenitor cells: are autologous cells preferable to allogeneic? |
| Q35285830 | Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet? |
| Q39317412 | Islet Microencapsulation: Strategies and Clinical Status in Diabetes |
| Q80059639 | Islet cell transplantation today |
| Q35040810 | Islet transplantation for diabetes: current status and future prospects |
| Q35122215 | Islet transplantation, stem cells, and transfusion medicine |
| Q64969880 | Islet-Like Structures Generated In Vitro from Adult Human Liver Stem Cells Revert Hyperglycemia in Diabetic SCID Mice. |
| Q38951189 | Mass production of functional human pancreatic β-cells: why and how? |
| Q34972402 | Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3. |
| Q38222504 | Mechanotransduction: tuning stem cells fate |
| Q38334043 | Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes |
| Q43828068 | Micro/nanoscale technologies for the development of hormone-expressing islet-like cell clusters. |
| Q98289181 | Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue |
| Q90036861 | Modelling the endocrine pancreas in health and disease |
| Q35546573 | Molecular development of the pancreatic β cell: implications for cell replacement therapy |
| Q34673909 | Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells |
| Q40676189 | Nestin action during insulin-secreting cell differentiation |
| Q60192349 | NeuroD and reaggregation induce β-cell specific gene expression in cultured hepatocytes |
| Q43002812 | Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells. |
| Q37535972 | New era in health care: tissue engineering |
| Q36186494 | New sources of pancreatic beta-cells |
| Q39198810 | Non insulin producing cell line, MIA PaCa-2 is rendered insulin producing in vitro via mesenchymal epithelial transition. |
| Q38169550 | Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells. |
| Q36707806 | Nuclear transfer: preservation of a nuclear genome at the expense of its associated mtDNA genome(s). |
| Q38045221 | Organ engineering--combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation |
| Q21092222 | PAX4 enhances beta-cell differentiation of human embryonic stem cells |
| Q37765396 | Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment |
| Q35585661 | Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation |
| Q34136625 | Pancreatic organogenesis--developmental mechanisms and implications for therapy |
| Q37187159 | Parthenogenesis-derived multipotent stem cells adapted for tissue engineering applications. |
| Q39206886 | Pdx1 protein induces human embryonic stem cells into the pancreatic endocrine lineage |
| Q42280966 | Pleiotropic Roles of PDX-1 in the Pancreas |
| Q36029693 | Pluripotent Stem Cells and Skeletal Regeneration--Promise and Potential |
| Q35024330 | Pluripotent stem cells--model of embryonic development, tool for gene targeting, and basis of cell therapy |
| Q35605784 | Potential of embryonic and adult stem cells in vitro. |
| Q37148319 | Potential role of stem cell therapy in type 1 diabetes mellitus |
| Q29616179 | Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells |
| Q38651610 | Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices |
| Q34117889 | Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes |
| Q37407901 | Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein |
| Q50234761 | RETRACTED: Survival and function of transplanted islet cells on an in vivo, vascularized tissue engineering platform in the rat: A pilot study |
| Q46386891 | Reactive Oxygen Species Shielding Hydrogel for the Delivery of Adherent and Nonadherent Therapeutic Cell Types |
| Q24674625 | Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3 |
| Q26767096 | Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells |
| Q37878871 | Recent advances in stem cell research for the treatment of diabetes |
| Q35144025 | Regeneration therapy for diabetes mellitus |
| Q34808566 | Regeneration therapy of pancreatic beta cells: towards a cure for diabetes? |
| Q37768701 | Regenerative medicine for insulin deficiency: creation of pancreatic islets and bioartificial pancreas |
| Q46664273 | Remission of diabetes by beta-cell regeneration in diabetic mice treated with a recombinant adenovirus expressing betacellulin. |
| Q38705454 | Reprogramming mouse embryo fibroblasts to functional islets without genetic manipulation. |
| Q36796419 | Reprogramming of bone marrow-derived mesenchymal stem cells into functional insulin-producing cells by chemical regimen |
| Q37994917 | Restoring insulin production for type 1 diabetes. |
| Q40488086 | Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45(neg)PFV hemogenic precursors |
| Q35163469 | Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells |
| Q44660894 | Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. |
| Q47794085 | Serum replacement with albumin-associated lipids prevents excess aggregation and enhances growth of induced pluripotent stem cells in suspension culture |
| Q40376832 | Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines |
| Q36882233 | Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes |
| Q33647542 | Slow and steady is the key to beta-cell replication |
| Q92635429 | Stem Cell Therapies in Kidney Diseases: Progress and Challenges |
| Q36127641 | Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases |
| Q38759783 | Stem Cells for Diabetes Complications: A Future Potential Cure |
| Q35779353 | Stem cell bioengineering for regenerative medicine |
| Q39950869 | Stem cell labeling using polyethylenimine conjugated (α-NaYbF4:Tm3+)/CaF2 upconversion nanoparticles. |
| Q37109618 | Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders |
| Q26865849 | Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications |
| Q37416022 | Stem cell therapy to treat diabetes mellitus |
| Q36804500 | Stem cell-based therapy for the treatment of Type 1 diabetes mellitus |
| Q37157674 | Stem cell-based therapy in gastroenterology and hepatology |
| Q36228883 | Stem cells |
| Q34784750 | Stem cells and their clinical application |
| Q33982394 | Stem cells as a therapeutic target for diabetes. |
| Q42324113 | Stem cells as a tool to improve outcomes of islet transplantation |
| Q34655280 | Stem cells for obstetricians and gynecologists |
| Q36309570 | Stem cells in the treatment of diabetes |
| Q37305062 | Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy |
| Q35707619 | Stem cells today: A. Origin and potential of embryo stem cells |
| Q36368236 | Stem cells, tissue engineering and organogenesis in transplantation |
| Q35622965 | Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes |
| Q31039213 | Stem cells: hype or hope? |
| Q35832775 | Stem-cell therapy for diabetes mellitus. |
| Q35047249 | Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus |
| Q39978987 | Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system |
| Q58047155 | Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation |
| Q35083934 | Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells |
| Q53221542 | The characterisation and functional β-cell differentiation of duck pancreas-derived mesenchymal cells. |
| Q42339159 | The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus |
| Q36426351 | The potential for stem cell therapy in diabetes. |
| Q34475454 | The prospect of induced pluripotent stem cells for diabetes mellitus treatment |
| Q38912666 | The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds |
| Q37209658 | The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration |
| Q34808935 | The use of in situ bone marrow stem cells for the treatment of various degenerative diseases |
| Q35749925 | Therapeutic cloning and tissue engineering |
| Q35781204 | Therapeutic cloning applications for organ transplantation |
| Q37121175 | Therapeutic potential of human embryonic stem cells in type 2 diabetes mellitus |
| Q85706345 | Tissue engineering |
| Q35546159 | Tissue engineering: current strategies and future directions |
| Q28083650 | Toward beta cell replacement for diabetes |
| Q45964326 | Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. |
| Q41862814 | Transforming growth factor (TGF)beta, fibroblast growth factor (FGF) and retinoid signalling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells |
| Q43457588 | Transplantation models to characterize the mechanisms of stem cell-induced islet regeneration |
| Q63246521 | Two decades of embryonic stem cells: a historical overview |
| Q53181372 | Unwinding the Novel Genes Involved in the Differentiation of Embryonic Stem Cells into Insulin-Producing Cells: A Network-Based Approach. |
| Q28601697 | Use of Mesenchymal Stem Cell-Conditioned Medium to Activate Islets in Preservation Solution |
| Q84282950 | [Neuroendocrine system of the pancreas and gastrointestinal tract: origin and development] |
| Q39369744 | iPSC technology-based regenerative therapy for diabetes. |
Search more.